HEADER OXIDOREDUCTASE 30-JAN-08 2VN0 TITLE CYP2C8DH COMPLEXED WITH TROGLITAZONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 2C8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 28-490; COMPND 5 SYNONYM: CYPIIC8, P450 FORM 1, P450 MP- 12/MP-20, P450 IIC2, S- COMPND 6 MEPHENYTOIN 4-HYDROXYLASE; COMPND 7 EC: 1.14.14.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH5[ALPHA]; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, ELECTRON TRANSPORT, ENDOPLASMIC RETICULUM, METAL- KEYWDS 2 BINDING, PALMITIC ACID, HUMAN P450 2C8, TROGLITAZONE, POLYMORPHISM, KEYWDS 3 MONOOXYGENASE, IRON, HEME, CYP2C8, MEMBRANE, MICROSOME, KEYWDS 4 MONOOXYGENASES, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.A.SCHOCH,J.K.YANO,S.SANSEN,C.D.STOUT,E.F.JOHNSON REVDAT 7 13-DEC-23 2VN0 1 REMARK LINK REVDAT 6 06-FEB-19 2VN0 1 REMARK REVDAT 5 30-JAN-19 2VN0 1 REMARK REVDAT 4 28-FEB-18 2VN0 1 SOURCE JRNL REVDAT 3 24-FEB-09 2VN0 1 VERSN REVDAT 2 01-JUL-08 2VN0 1 JRNL REMARK REVDAT 1 29-APR-08 2VN0 0 JRNL AUTH G.A.SCHOCH,J.K.YANO,S.SANSEN,P.M.DANSETTE,C.D.STOUT, JRNL AUTH 2 E.F.JOHNSON JRNL TITL DETERMINANTS OF CYTOCHROME P450 2C8 SUBSTRATE BINDING: JRNL TITL 2 STRUCTURES OF COMPLEXES WITH MONTELUKAST, TROGLITAZONE, JRNL TITL 3 FELODIPINE, AND 9-CIS-RETINOIC ACID. JRNL REF J. BIOL. CHEM. V. 283 17227 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18413310 JRNL DOI 10.1074/JBC.M802180200 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1634289.670 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 23134 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1167 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3609 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 193 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3703 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.88000 REMARK 3 B22 (A**2) : 12.90000 REMARK 3 B33 (A**2) : -7.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 32.84 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VN0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1290035147. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : SIDE-SCATTERING CUBEROOT I- BEAM REMARK 200 BENT SINGLE CRYSTAL ASYMETRIC REMARK 200 CUT 12.2 DEGS. REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR SINGLE REMARK 200 CRYSTAL SI(311) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23135 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 47.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1PQ2 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, HEPES, LISO4, MEOH, PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.10000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 68.04500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 81.62000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.10000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 68.04500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 81.62000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.10000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 68.04500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 81.62000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.10000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 68.04500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.62000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 19 REMARK 465 ALA A 20 REMARK 465 LYS A 21 REMARK 465 LYS A 22 REMARK 465 THR A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 LYS A 26 REMARK 465 GLY A 27 REMARK 465 HIS A 492 REMARK 465 HIS A 493 REMARK 465 HIS A 494 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE A 355 OG SER A 359 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 37 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 31 -176.11 -53.18 REMARK 500 PRO A 37 -36.36 -15.65 REMARK 500 ASP A 49 53.22 -161.06 REMARK 500 ILE A 88 -66.31 -97.38 REMARK 500 MET A 136 57.99 -148.40 REMARK 500 THR A 159 4.99 -69.67 REMARK 500 ALA A 161 5.23 57.72 REMARK 500 THR A 167 -70.90 -33.53 REMARK 500 GLN A 184 -91.14 119.10 REMARK 500 SER A 280 129.02 -34.97 REMARK 500 THR A 299 -76.17 -85.10 REMARK 500 ARG A 377 -127.73 56.62 REMARK 500 ASN A 378 30.95 -96.96 REMARK 500 LEU A 390 83.93 -65.91 REMARK 500 LYS A 415 -38.98 -39.87 REMARK 500 SER A 429 -153.51 76.90 REMARK 500 CYS A 435 125.12 -32.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 435 SG REMARK 620 2 HEM A 500 NA 91.6 REMARK 620 3 HEM A 500 NB 92.4 89.1 REMARK 620 4 HEM A 500 NC 83.3 174.8 91.8 REMARK 620 5 HEM A 500 ND 88.0 89.8 178.8 89.3 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TDZ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLM A 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PQ2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROMEP450 2C8 REMARK 900 RELATED ID: 2NNJ RELATED DB: PDB REMARK 900 CYP2C8DH COMPLEXED WITH FELODIPINE REMARK 900 RELATED ID: 2NNH RELATED DB: PDB REMARK 900 CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID REMARK 900 RELATED ID: 2NNI RELATED DB: PDB REMARK 900 CYP2C8DH COMPLEXED WITH MONTELUKAST REMARK 999 REMARK 999 SEQUENCE REMARK 999 REPLACEMENT OF RESIDUES 1-27 WITH THE SEQUENCE MAKKTSSKG, REMARK 999 ADDITION OF A C-TERMINAL 4 RESIDUE HISTIDINE TAG (RESIDUES REMARK 999 491-494) DBREF 2VN0 A 19 27 PDB 2VN0 2VN0 19 27 DBREF 2VN0 A 28 490 UNP P10632 CP2C8_HUMAN 28 490 DBREF 2VN0 A 491 494 PDB 2VN0 2VN0 491 494 SEQRES 1 A 476 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO SEQRES 2 A 476 GLY PRO THR PRO LEU PRO ILE ILE GLY ASN MET LEU GLN SEQRES 3 A 476 ILE ASP VAL LYS ASP ILE CYS LYS SER PHE THR ASN PHE SEQRES 4 A 476 SER LYS VAL TYR GLY PRO VAL PHE THR VAL TYR PHE GLY SEQRES 5 A 476 MET ASN PRO ILE VAL VAL PHE HIS GLY TYR GLU ALA VAL SEQRES 6 A 476 LYS GLU ALA LEU ILE ASP ASN GLY GLU GLU PHE SER GLY SEQRES 7 A 476 ARG GLY ASN SER PRO ILE SER GLN ARG ILE THR LYS GLY SEQRES 8 A 476 LEU GLY ILE ILE SER SER ASN GLY LYS ARG TRP LYS GLU SEQRES 9 A 476 ILE ARG ARG PHE SER LEU THR THR LEU ARG ASN PHE GLY SEQRES 10 A 476 MET GLY LYS ARG SER ILE GLU ASP ARG VAL GLN GLU GLU SEQRES 11 A 476 ALA HIS CYS LEU VAL GLU GLU LEU ARG LYS THR LYS ALA SEQRES 12 A 476 SER PRO CYS ASP PRO THR PHE ILE LEU GLY CYS ALA PRO SEQRES 13 A 476 CYS ASN VAL ILE CYS SER VAL VAL PHE GLN LYS ARG PHE SEQRES 14 A 476 ASP TYR LYS ASP GLN ASN PHE LEU THR LEU MET LYS ARG SEQRES 15 A 476 PHE ASN GLU ASN PHE ARG ILE LEU ASN SER PRO TRP ILE SEQRES 16 A 476 GLN VAL CYS ASN ASN PHE PRO LEU LEU ILE ASP CYS PHE SEQRES 17 A 476 PRO GLY THR HIS ASN LYS VAL LEU LYS ASN VAL ALA LEU SEQRES 18 A 476 THR ARG SER TYR ILE ARG GLU LYS VAL LYS GLU HIS GLN SEQRES 19 A 476 ALA SER LEU ASP VAL ASN ASN PRO ARG ASP PHE ILE ASP SEQRES 20 A 476 CYS PHE LEU ILE LYS MET GLU GLN GLU LYS ASP ASN GLN SEQRES 21 A 476 LYS SER GLU PHE ASN ILE GLU ASN LEU VAL GLY THR VAL SEQRES 22 A 476 ALA ASP LEU PHE VAL ALA GLY THR GLU THR THR SER THR SEQRES 23 A 476 THR LEU ARG TYR GLY LEU LEU LEU LEU LEU LYS HIS PRO SEQRES 24 A 476 GLU VAL THR ALA LYS VAL GLN GLU GLU ILE ASP HIS VAL SEQRES 25 A 476 ILE GLY ARG HIS ARG SER PRO CYS MET GLN ASP ARG SER SEQRES 26 A 476 HIS MET PRO TYR THR ASP ALA VAL VAL HIS GLU ILE GLN SEQRES 27 A 476 ARG TYR SER ASP LEU VAL PRO THR GLY VAL PRO HIS ALA SEQRES 28 A 476 VAL THR THR ASP THR LYS PHE ARG ASN TYR LEU ILE PRO SEQRES 29 A 476 LYS GLY THR THR ILE MET ALA LEU LEU THR SER VAL LEU SEQRES 30 A 476 HIS ASP ASP LYS GLU PHE PRO ASN PRO ASN ILE PHE ASP SEQRES 31 A 476 PRO GLY HIS PHE LEU ASP LYS ASN GLY ASN PHE LYS LYS SEQRES 32 A 476 SER ASP TYR PHE MET PRO PHE SER ALA GLY LYS ARG ILE SEQRES 33 A 476 CYS ALA GLY GLU GLY LEU ALA ARG MET GLU LEU PHE LEU SEQRES 34 A 476 PHE LEU THR THR ILE LEU GLN ASN PHE ASN LEU LYS SER SEQRES 35 A 476 VAL ASP ASP LEU LYS ASN LEU ASN THR THR ALA VAL THR SEQRES 36 A 476 LYS GLY ILE VAL SER LEU PRO PRO SER TYR GLN ILE CYS SEQRES 37 A 476 PHE ILE PRO VAL HIS HIS HIS HIS HET HEM A 500 43 HET TDZ A 501 31 HET PLM A 502 18 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM TDZ (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4- HETNAM 2 TDZ DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3- HETNAM 3 TDZ THIAZOLIDINE-2,4-DIONE HETNAM PLM PALMITIC ACID HETSYN HEM HEME HETSYN TDZ TROGLITAZONE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 TDZ C24 H27 N O5 S FORMUL 4 PLM C16 H32 O2 FORMUL 5 HOH *30(H2 O) HELIX 1 1 ASN A 41 ILE A 45 5 5 HELIX 2 2 ASP A 49 GLY A 62 1 14 HELIX 3 3 GLY A 79 ILE A 88 1 10 HELIX 4 4 SER A 100 LYS A 108 1 9 HELIX 5 5 ASN A 116 LEU A 131 1 16 HELIX 6 6 SER A 140 THR A 159 1 20 HELIX 7 7 PRO A 166 PHE A 183 1 18 HELIX 8 8 ASP A 191 ASN A 209 1 19 HELIX 9 9 SER A 210 PHE A 219 1 10 HELIX 10 10 PRO A 220 CYS A 225 5 6 HELIX 11 11 PHE A 226 SER A 254 1 29 HELIX 12 12 ASP A 262 LYS A 275 1 14 HELIX 13 13 ASN A 283 THR A 299 1 17 HELIX 14 14 THR A 299 HIS A 316 1 18 HELIX 15 15 HIS A 316 ILE A 331 1 16 HELIX 16 16 CYS A 338 HIS A 344 5 7 HELIX 17 17 MET A 345 ASP A 360 1 16 HELIX 18 18 LEU A 390 HIS A 396 1 7 HELIX 19 19 ASP A 408 PHE A 412 5 5 HELIX 20 20 ALA A 430 ILE A 434 5 5 HELIX 21 21 GLY A 437 GLN A 454 1 18 HELIX 22 22 ASP A 463 LEU A 467 5 5 SHEET 1 AA 5 VAL A 64 PHE A 69 0 SHEET 2 AA 5 ASN A 72 PHE A 77 -1 O ASN A 72 N PHE A 69 SHEET 3 AA 5 THR A 386 ALA A 389 1 O THR A 386 N VAL A 75 SHEET 4 AA 5 HIS A 368 ALA A 369 -1 O HIS A 368 N ILE A 387 SHEET 5 AA 5 GLY A 96 ARG A 97 -1 O GLY A 96 N ALA A 369 SHEET 1 AB 3 PRO A 163 CYS A 164 0 SHEET 2 AB 3 ILE A 485 PRO A 489 -1 O ILE A 485 N CYS A 164 SHEET 3 AB 3 PHE A 456 SER A 460 -1 O ASN A 457 N ILE A 488 SHEET 1 AC 2 THR A 374 PHE A 376 0 SHEET 2 AC 2 TYR A 379 ILE A 381 -1 O TYR A 379 N PHE A 376 LINK SG CYS A 435 FE HEM A 500 1555 1555 2.27 SITE 1 AC1 19 ARG A 97 ILE A 112 TRP A 120 ARG A 124 SITE 2 AC1 19 ALA A 297 GLY A 298 THR A 301 THR A 302 SITE 3 AC1 19 THR A 305 LEU A 361 VAL A 366 HIS A 368 SITE 4 AC1 19 PRO A 427 PHE A 428 SER A 429 ARG A 433 SITE 5 AC1 19 CYS A 435 ALA A 436 GLU A 444 SITE 1 AC2 8 ILE A 106 PHE A 201 ASN A 204 PHE A 205 SITE 2 AC2 8 LEU A 208 ARG A 241 VAL A 296 GLU A 300 SITE 1 AC3 7 ARG A 105 ILE A 106 PHE A 226 PRO A 227 SITE 2 AC3 7 GLY A 228 THR A 229 LEU A 234 CRYST1 74.200 136.090 163.240 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013477 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007348 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006126 0.00000